Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 7/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.65 |
| ▸ | BCHE | P06276 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 6/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | ALPL | P05186 | 1/20 | 0.61 |
| ▸ | ALPG | P10696 | 1/20 | 0.61 |
| ▸ | GCGR | P47871 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29770390 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2HPGDRAB9AHSD17B10 | |
| SCHEMBL14304382 | 0.89 | KMT2A (0.79) | KMT2ASMN1; SMN2HPGDRAB9AHSD17B10 | |
| SCHEMBL4673914 | 0.88 | KMT2A (0.78) | KMT2ASMN1; SMN2HPGDRAB9AHSD17B10 | |
| SCHEMBL8251328 | 0.87 | KMT2A (0.77) | KMT2ASMN1; SMN2HPGDRAB9AHSD17B10 | |
| SCHEMBL15474114 | 0.86 | KMT2A (0.75) | KMT2ASMN1; SMN2HPGDRAB9AHSD17B10 | |
| SCHEMBL8797365 | 0.86 | KMT2A (0.75) | KMT2ASMN1; SMN2HPGDRAB9AHSD17B10 | |
| SCHEMBL10762447 | 0.84 | KMT2A (0.73) | KMT2ASMN1; SMN2HPGDRAB9AHSD17B10 | |
| SCHEMBL10890184 | 0.84 | KMT2A (0.73) | KMT2ASMN1; SMN2RAB9ABCHENPC1 | |
| SCHEMBL8425964 | 0.83 | SMN1; SMN2 (0.79) | KMT2ASMN1; SMN2HPGDRAB9AHSD17B10 | |
| SCHEMBL12485740 | 0.83 | MPO (0.81) | KMT2ASMN1; SMN2RAB9APOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114766506-B | Chlorine dioxide disinfectant and preparation method and application thereof | 广东环凯生物技术有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-114766506-A | Chlorine dioxide disinfectant and preparation method and application thereof | 广东环凯生物技术有限公司 | 2022-07-22 | — | — | CN | claimed |
| US-20240132479-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2024-04-25 | — | — | US | disclosed |
| CN-114766506-B | Chlorine dioxide disinfectant and preparation method and application thereof | 广东环凯生物技术有限公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-114766506-A | Chlorine dioxide disinfectant and preparation method and application thereof | 广东环凯生物技术有限公司 | 2022-07-22 | — | — | CN | disclosed |
| EP-3611224-A1 | COMPOSITION, COMPOSITE FILM AND MEMBRANE ELECTRODE ASSEMBLY | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2020-02-19 | — | — | EP | disclosed |
| US-20140275224-A1 | CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2014-09-18 | — | — | US | disclosed |
| WO-2013074059-A2 | CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2013-05-23 | — | — | WO | disclosed |
| US-8278327-B2 | PDE10 inhibitors and related compositions and methods | OMEROS CORPORATION (US) | 2012-10-02 | — | — | US | disclosed |
| US-20120116027-A1 | PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS | NOVO NORDISK A/S (DK) | 2012-05-10 | — | — | US | disclosed |
| CN-1709870-B | Optical-purity N',N'-dibasic prolyl hydrazine compound, and its preparing method and use | CHENGDU BIOLOGY INST CHINESE ACADEMY OF SCIENCES | 2011-07-06 | — | — | CN | disclosed |
| WO-1995012590-A1 | PREPARATION OF OMEPRAZOLE AND LANSOPRAZOLE AND INTERMEDIATES USEFUL THEREIN | TORCAN CHEMICAL LTD. (CA) | 1995-05-11 | — | — | WO | disclosed |
| US-5374730-A | Preparation of omeprazole and lansoprazole | TORCAN CHEMICAL LTD. (CA) | 1994-12-20 | — | — | US | disclosed |
| US-4762848-A | IMMUNE SYSTEM STIMULANTS, CYTOSTATIC AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-08-09 | — | — | US | disclosed |
| EP-0194572-A1 | Heterocyclic sulfides, process for their preparation and Medicaments containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-09-17 | — | — | EP | disclosed |
| US-4528286-A | Method of using certain aryl-mercapto-lower-alkanamides as antiseborrheic agents | HENKEL KOMMANDITGESELLSCHAFT (KGAA) (DE) | 1985-07-09 | — | — | US | disclosed |
| EP-0128862-A2 | Anti-corrosive coating composition | CIBA-GEIGY AG (CH) | 1984-12-19 | — | — | EP | disclosed |
| EP-0006347-B1 | COMPOSITIONS AND METHOD FOR REGULATING SOYBEAN PLANT GROWTH UTILIZING SUBSTITUTED BENZAZOLYLTHIOALKANOIC ACIDS | MONSANTO COMPANY (US) | 1984-01-25 | — | — | EP | disclosed |
| US-4391886-A | Methine colorant materials and the use thereof in electrophoretic migration imaging layers and processes | EASTMAN KODAK COMPANY (US) | 1983-07-05 | — | — | US | disclosed |
| US-4304908-A | Methine colorant materials and the use thereof in electrophoretic migration imaging layers and processes | EASTMAN KODAK COMPANY (US) | 1981-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120116027-A1 | PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS | GHRHR, GHITM, GHSR | KMT2A 3404/4885SMN1; SMN2 4684/4885HPGD 1448/4885 |
| US-20240132479-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | CUTA, DCXR, PLOD3 | KMT2A 2269/4885SMN1; SMN2 560/4885HPGD 4181/4885 |
| US-20140275224-A1 | CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION | CDA, DCTD, ADA | KMT2A 1471/4885SMN1; SMN2 2561/4885HPGD 1501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.